🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07831785
Starting soon Not applicable

Supportive Care During Childbirth in Syrian Migrant Women

NCT07831785 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-09-24

Condition(s) studied

Childbirth

Investigational drug(s) / intervention(s)

Structured Supportive Midwifery Care

Structured Supportive Midwifery Care: Structured supportive midwifery care will be provided by the researcher midwife throughout labor in addition to routine hospital care. The intervention consists of four components: physical support, emotional support, informational and communication support, and advocacy. Physical support includes mobilization, position changes, breathing and relaxation techniques, massage, sacral pressure, touch, and comfort measures according to the woman's needs. Emotional support includes continuous presence, reassurance, encouragement, empathetic communication, and respect for privacy. Informational and communication support includes explanations about the labor process and procedures, guidance on breathing and pushing techniques, and early postpartum and breastfeeding education. Advocacy includes supporting the woman's preferences, participation in decision-making, privacy, and communication with healthcare professionals.

Study summary

This randomized controlled trial aims to evaluate the effects of structured supportive midwifery care provided during labor on childbirth satisfaction, breastfeeding success, breastfeeding self-efficacy, and perceived stress among Syrian migrant women. A total of 100 eligible women admitted to the delivery unit of Yuregir State Hospital in Adana, Türkiye, will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. Women in the intervention group will receive structured supportive midwifery care in addition to routine hospital care, whereas women in the control group will receive routine maternity care. The supportive care intervention will include physical support, emotional support, informational and communication support, and advocacy throughout labor. Outcomes will be assessed using validated measurement tools during the childbirth and early postpartum periods.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Syrian migrant women admitted to the Delivery Unit of Adana Yüreğir State Hospital due to labor. * Aged 18 years or older. * Gestational age between 37 and 42 weeks. * Singleton, live pregnancy. * Fetus in cephalic presentation. * Spontaneous vaginal labor initiated and in the active phase of labor. * Able to communicate in Arabic or Turkish at a level sufficient to understand the data collection instruments and the intervention to be applied. * Voluntarily agreeing to participate in the study and providing informed consent. Exclusion Criteria: * Having a planned (elective) cesarean delivery decision at the time of admission. * Having an obstetric condition contraindicating vaginal delivery. * Having a high-risk pregnancy or labor condition, including severe preeclampsia, eclampsia, placenta previa, or placental abruption. * Multiple pregnancy. * Intrauterine fetal death or a major fetal anomaly incompatible with life. * Having a maternal or fetal clinical condition requiring emergency obstetric intervention at the time of admission for labor. * Having a cognitive impairment or severe psychiatric condition that would prevent participation, communication, or the informed consent process.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Adana Yuregir State Hospital Adana Turkey (Türkiye)

More Tarsus University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07831785 on ClinicalTrials.gov ↗ ← All trials in Turkey